Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Background: Most studies of long-term exposure to outdoor fine particulate matter (PM2·5) and cardiovascular disease are from high-income countries with relatively low PM2·5 concentrations. It is unclear whether risks are similar in low-income and middle-income countries (LMICs) and how outdoor PM2·...
Similar Items
-
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
by: Yusuf S.; Joseph P.; Rangarajan S.; Islam S.; Mente A.; Hystad P.; Brauer M.; Kutty V.R.; Gupta R.; Wielgosz A.; AlHabib K.F.; Dans A.; Lopez-Jaramillo P.; Avezum A.; Lanas F.; Oguz A.; Kruger I.M.; Diaz R.; Yusoff K.; Mony P.; Chifamba J.; Yeates K.; Kelishadi R.; Yusufali A.; Khatib R.; Rahman O.; Zatonska K.; Iqbal R.; Wei L.; Bo H.; Rosengren A.; Kaur M.; Mohan V.; Lear S.A.; Teo K.K.; Leong D.; O'Donnell M.; McKee M.; Dagenais G.
Published: (2020) -
Association of Sitting Time with Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries
by: Li S.; Lear S.A.; Rangarajan S.; Hu B.; Yin L.; Bangdiwala S.I.; Alhabib K.F.; Rosengren A.; Gupta R.; Mony P.K.; Wielgosz A.; Rahman O.; Mazapuspavina M.Y.; Avezum A.; Oguz A.; Yeates K.; Lanas F.; Dans A.; Abat M.E.M.; Yusufali A.; Diaz R.; Lopez-Jaramillo P.; Leach L.; Lakshmi P.V.M.; Basiak-Rasała A.; Iqbal R.; Kelishadi R.; Chifamba J.; Khatib R.; Li W.; Yusuf S.
Published: (2022) -
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
by: Chow C.K.; Nguyen T.N.; Marschner S.; Diaz R.; Rahman O.; Avezum A.; Lear S.A.; Teo K.; Yeates K.E.; Lanas F.; Li W.; Hu B.; Lopez-Jaramillo P.; Gupta R.; Kumar R.; Mony P.K.; Bahonar A.; Yusoff K.; Khatib R.; Kazmi K.; Dans A.L.; Zatonska K.; Alhabib K.F.; Kruger I.M.; Rosengren A.; Gulec S.; Yusufali A.; Chifamba J.; Rangarajan S.; McKee M.; Yusuf S.
Published: (2020) -
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
by: Chow C.K.; Ramasundarahettige C.; Hu W.; AlHabib K.F.; Avezum A., et al.
Published: (2018) -
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data
by: Khatib R.; McKee M.; Shannon H.; Chow C.; Rangarajan S.; Teo K.; Wei L.; Mony P.; Mohan V.; Gupta R.; Kumar R.; Vijayakumar K.; Lear S.A.; Diaz R.; Avezum A.; Lopez-Jaramillo P.; Lanas F.; Yusoff K.; Ismail N.; Kazmi K.; Rahman O.; Rosengren A.; Monsef N.; Kelishadi R.; Kruger A.; Puoane T.; Szuba A.; Chifamba J.; Temizhan A.; Dagenais G.; Gafni A.; Yusuf S.
Published: (2016)